Tertiary lymphoid structures localization and maturation heterogeneities correlate with divergent clinical outcomes and immune responses of clear cell renal cell carcinoma

被引:0
|
作者
Ye, D. [1 ]
Xu, W. [2 ]
Zhang, H. [2 ]
机构
[1] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
[2] Fudan Univ, Shanghai Canc Ctr, Urol, Shanghai, Peoples R China
关键词
D O I
10.1016/j.annonc.2023.09.2198
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
1059P
引用
收藏
页码:S641 / S641
页数:1
相关论文
共 50 条
  • [1] Tertiary lymphoid structures localization and maturation heterogeneities correlate with divergent microenvironment features and immune responses of clear cell renal cell carcinoma
    Xu, W.
    Zhang, H.
    Ye, D.
    Liu, W.
    ANNALS OF ONCOLOGY, 2023, 34 : S1623 - S1623
  • [2] Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
    Xu, Wenhao
    Lu, Jiahe
    Tian, Xi
    Ye, Shiqi
    Wei, Shiyin
    Wang, Jun
    Anwaier, Aihetaimujiang
    Qu, Yuanyuan
    Liu, Wangrui
    Chang, Kun
    Zhang, Hailiang
    Ye, Dingwei
    MEDCOMM, 2024, 5 (01):
  • [3] Heterogeneity in tertiary lymphoid structures predicts the distinct prognosis and immune microenvironment of clear cell renal cell carcinoma
    Xu, W.
    Zhang, H.
    Ye, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S1026 - S1026
  • [4] Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma
    Xu, Wenhao
    Lu, Jiahe
    Liu, Wang-Rui
    Anwaier, Aihetaimujiang
    Wu, Yuhao
    Tian, Xi
    Su, Jia-Qi
    Qu, Yuan-Yuan
    Yang, Jianfeng
    Zhang, Hailiang
    Ye, Dingwei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (12)
  • [5] Heterogeneity in tertiary lymphoid structures predicts distinct prognosis and immune microenvironment characterizations of clear cell renal cell carcinoma
    Xu, W.
    Zhang, H.
    Ye, D.
    ANNALS OF ONCOLOGY, 2023, 34 : S1561 - S1561
  • [6] Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of renal cell carcinoma
    Ye, D.
    Xu, W.
    Aihetaimujiang, A.
    Lu, J.
    Ye, S.
    Zhou, S.
    Zhang, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1518 - S1518
  • [7] Eosinophilic features in clear cell renal cell carcinoma correlate with outcomes of immune checkpoint and angiogenesis blockade
    Yoshida, Takashi
    Ohe, Chisato
    Ikeda, Junichi
    Atsumi, Naho
    Ohsugi, Haruyuki
    Sugi, Motohiko
    Higasa, Koichiro
    Saito, Ryoichi
    Tsuta, Koji
    Matsuda, Tadashi
    Kinoshita, Hidefumi
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (09)
  • [8] Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients
    Jiang, Wenbin
    Zeng, Han
    Liu, Zhaopei
    Jin, Kaifeng
    Hu, Baoying
    Chang, Yuan
    Liu, Li
    Zhu, Yu
    Xu, Le
    Wang, Zewei
    Guo, Jianming
    Xu, Jiejie
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2022, 40 (04) : 166.e15 - 166.e25
  • [9] Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma
    Shoichi Nakamura
    Kenoki Ohuchida
    Masataka Hayashi
    Naoki Katayama
    Chikanori Tsutsumi
    Yutaka Yamada
    Kyoko Hisano
    Sho Okuda
    Yoshiki Ohtsubo
    Chika Iwamoto
    Nobuhiro Torata
    Yusuke Mizuuchi
    Koji Shindo
    Kohei Nakata
    Taiki Moriyama
    Takashi Morisaki
    Yoshinao Oda
    Masafumi Nakamura
    British Journal of Cancer, 2023, 129 : 1314 - 1326
  • [10] Tertiary lymphoid structures correlate with enhancement of antitumor immunity in esophageal squamous cell carcinoma
    Nakamura, Shoichi
    Ohuchida, Kenoki
    Hayashi, Masataka
    Katayama, Naoki
    Tsutsumi, Chikanori
    Yamada, Yutaka
    Hisano, Kyoko
    Okuda, Sho
    Ohtsubo, Yoshiki
    Iwamoto, Chika
    Torata, Nobuhiro
    Mizuuchi, Yusuke
    Shindo, Koji
    Nakata, Kohei
    Moriyama, Taiki
    Morisaki, Takashi
    Oda, Yoshinao
    Nakamura, Masafumi
    BRITISH JOURNAL OF CANCER, 2023, 129 (08) : 1314 - 1326